Travere Therapeutics (TVTX) EBITDA Margin (2014 - 2026)
Travere Therapeutics' EBITDA Margin came in at 4.83% for Q2 2026, up 3.63 percentage points from 1.19% a year earlier and up 14.03 percentage points from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) EBITDA Margin (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Travere Therapeutics reported EBITDA Margin of 3.87%, up 40.43 percentage points year-over-year; for FY2025, it was -0.42%, up 119.77 percentage points from FY2024.
- EBITDA Margin has increased in each of the last four years, with a five-year change of +76.01 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -120.20% in FY2024 (+120.52 pp), -240.71% in FY2023 (+32.53 pp), -273.25% in FY2022 (+1282.41 pp) and -1555.66% in FY2021 (-1479.22 pp).
- The five-year range for quarterly EBITDA Margin is -772.26% (Q4 2021) to 24.70% (Q3 2025).
- Year-over-year, EBITDA Margin has increased for nine consecutive quarters, with an average year-over-year change of +104.34 percentage points over the last eight quarters.
- The fastest year-over-year change in EBITDA Margin over five years came in Q4 2022 (a gain of 498.25 percentage points), and the weakest in Q4 2021 (a drop of 552.74 percentage points).
- Business Quant data shows TVTX's EBITDA Margin at -9.20% (Q1 2026), -11.02% (Q4 2025) and 24.70% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Travere Therapeutics | 5.65 Bn | 5.25 Bn | 167.41 Mn | 4.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.83% |
| Mar 31, 2026 | -9.20% |
| Dec 31, 2025 | -11.02% |
| Sep 30, 2025 | 24.70% |
| Jun 30, 2025 | 1.19% |
| Mar 31, 2025 | -36.55% |
| Dec 31, 2024 | -65.05% |
| Sep 30, 2024 | -71.40% |
| Jun 30, 2024 | -105.99% |
| Mar 31, 2024 | -312.65% |
| Dec 31, 2023 | -188.08% |
| Sep 30, 2023 | -218.65% |
| Jun 30, 2023 | -288.87% |
| Mar 31, 2023 | -293.80% |
| Dec 31, 2022 | -274.00% |
| Sep 30, 2022 | -297.05% |
| Jun 30, 2022 | -245.92% |
| Mar 31, 2022 | -277.16% |
| Dec 31, 2021 | -772.26% |
| Sep 30, 2021 | -34.94% |
API Access
Travere Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();